Literature DB >> 8208338

Hirano bodies and related neuronal inclusions.

A Hirano1.   

Abstract

Hirano bodies are bright eosinophilic intracytoplasmic inclusions which have a highly characteristic crystalloid fine structure. They occur preferentially in the neuronal processes of the CA1 area in Ammon's horn in a wide variety of conditions, especially amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam, Alzheimer's disease, Pick's disease and 'normal' elderly individuals. Hirano bodies contain epitopes of actin, actin-associated proteins, tau, middle molecular weight neurofilaments subunit and a C-terminal fragment of beta-amyloid precursor protein. In addition to the CA1 area of Ammon's horn, they have also been identified in many other areas of the nervous system in humans and various experimental animals. Although usually observed in neurons, Hirano bodies may also be present in other cell types. It is the consensus that Hirano bodies in the pyramidal layer of CA1 originate largely from an age-related alteration of the microfilamentous system.

Entities:  

Mesh:

Year:  1994        PMID: 8208338     DOI: 10.1111/j.1365-2990.1994.tb00951.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  55 in total

1.  Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.

Authors:  Charles Y Shao; Suzanne S Mirra; Hameetha B R Sait; Todd C Sacktor; Einar M Sigurdsson
Journal:  Acta Neuropathol       Date:  2011-06-01       Impact factor: 17.088

2.  Demonstration and characterization of hippocampal cholinergic neurostimulating peptide (HCNP) processing enzyme activity in rat hippocampus.

Authors:  Y Otsuka; K Ojika
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

3.  Formation of Hirano bodies induced by expression of an actin cross-linking protein with a gain-of-function mutation.

Authors:  Andrew Maselli; Ruth Furukawa; Susanne A M Thomson; Richard C Davis; Marcus Fechheimer
Journal:  Eukaryot Cell       Date:  2003-08

4.  15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cells.

Authors:  Jinming Zhao; Valerie B O'Donnell; Silvana Balzar; Claudette M St Croix; John B Trudeau; Sally E Wenzel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-09       Impact factor: 11.205

5.  Oxidative stress and 17-alpha- and 17-beta-estradiol modulate neurofilaments differently.

Authors:  Keith Chiasson; Vicky Lahaie-Collins; Julie Bournival; Benoit Delapierre; Sylvie Gélinas; Maria-Grazia Martinoli
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

6.  Formation of Hirano bodies after inducible expression of a modified form of an actin-cross-linking protein.

Authors:  Juan F Reyes; Karen Stone; Jeanie Ramos; Andrew Maselli
Journal:  Eukaryot Cell       Date:  2009-04-10

7.  Actin-binding proteins implicated in the formation of the punctate actin foci stimulated by the self-incompatibility response in Papaver.

Authors:  Natalie S Poulter; Christopher J Staiger; Joshua Z Rappoport; Vernonica E Franklin-Tong
Journal:  Plant Physiol       Date:  2010-01-15       Impact factor: 8.340

8.  Requirements for Hirano body formation.

Authors:  Paul Griffin; Ruth Furukawa; Cleveland Piggott; Andrew Maselli; Marcus Fechheimer
Journal:  Eukaryot Cell       Date:  2014-03-14

Review 9.  Transgenic Drosophila models of Alzheimer's disease and tauopathies.

Authors:  Kanae Iijima-Ando; Koichi Iijima
Journal:  Brain Struct Funct       Date:  2009-12-05       Impact factor: 3.270

10.  Autophagy contributes to degradation of Hirano bodies.

Authors:  Dong-Hwan Kim; Richard C Davis; Ruth Furukawa; Marcus Fechheimer
Journal:  Autophagy       Date:  2009-01       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.